Skip to main content

Table 3 Clinical response rates for the entire follow-up time and at the 12-months follow-up after treatment initiation

From: Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry

sJIA Good response Transient response Poor response
ANA CANA ANA CANA ANA CANA
Twelve months 79% (50/63) 95% (21/22)    21% (13/63) 5% (1/22)
Last follow-up 68% (54/80) 74% (20/27) 5% (4/80) 15% (4/27) 27% (22/80) 11% (3/27)